A61K 39 - Medicinal preparations containing antigens or antibodies

Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
12/2013
12/12/2013	WO2013184024A1 Preparation for increasing sperm production in stud livestock and roosters and method for the use thereof
12/12/2013	WO2013183786A1 Antibody against transporter and use thereof
12/12/2013	WO2013182668A1 Mutant selectivity and combinations of a phosphoinositide 3 kinase inhibitor compound and chemotherapeutic agents for the treatment of cancer
12/12/2013	WO2013182662A1 Vaccine
12/12/2013	WO2013182661A1 Peptides derived from viral proteins for use as immunogens and dosage reactants
12/12/2013	WO2013182660A1 Hiv vaccine
12/12/2013	WO2013182603A1 New n-glycans and uses thereof
12/12/2013	WO2013182537A1 Autoimmune antibodies
12/12/2013	WO2013182498A1 Improved safety testing
12/12/2013	WO2013181696A1 Vaccination with interleukin-4 antagonists
12/12/2013	WO2013181694A1 Compositions and methods for treating crohn's disease and related conditions and infections
12/12/2013	WO2013155320A3 Use of microbial gene products to prevent or treat microbial infections
12/12/2013	WO2013147628A3 Oral vaccine containing the bacillus subtilis spores and its application to immunise against helicobacter pylori
12/12/2013	WO2013143683A8 Rna formulation for immunotherapy
12/12/2013	WO2013108272A3 Blood stage malaria vaccine
12/12/2013	WO2012140417A3 Combination vaccine against staphyloccal infections
12/12/2013	WO2012134591A3 Plasmodium falciparum antigens
12/12/2013	WO2009128950A8 Deletion mutants of flagellin and methods of use
12/12/2013	US20130333059 Hox compositions and methods
12/12/2013	US20130330398 Method of Making Small Liposomes
12/12/2013	US20130330382 Fluorocarbon-linked peptide formulation
12/12/2013	US20130330375 Therapeutic Cancer Vaccine
12/12/2013	US20130330374 Treatment of immune disease by mucosal delivery of antigens using genetically modified lactobacillus
12/12/2013	US20130330369 Reduction Of Antibody Response Against Botulinum Neurotoxin And Variants Thereof
12/12/2013	US20130330363 Method of vaccination
12/12/2013	US20130330361 Composition Comprising Expression or Activity Regulators of AKAP12 for Treating Central Nerve System Diseases
12/12/2013	US20130330359 Composition and method for the diagnosis and treatment of iron-related disorders
12/12/2013	US20130330358 Crystal structure and peptide inhibitors of hausp deubiquitinase
12/12/2013	US20130330357 METHODS OF TREATING DISORDERS USING HUMAN ANTIBODIES THAT BIND HUMAN TNFalpha
12/12/2013	US20130330356 METHODS OF TREATING DISORDERS USING HUMAN ANTIBODIES THAT BIND HUMAN TNFalpha
12/12/2013	US20130330354 Stabilized liquid egg material for extended shelf life
12/12/2013	US20130330353 Regimens for treatments using anti-igf antibodies
12/12/2013	US20130330352 Treatment of myocardial infarction using tgf beta antagonists
12/12/2013	US20130330349 High affinity molecules capable of binding a type a plexin receptor and uses of same
12/12/2013	US20130330344 Antibody molecules having specificity for human ox40
12/12/2013	US20130330342 Antibody fragments inhibiting hiv nef protein
12/12/2013	US20130330335 Bioinformatic processes for determination of peptide binding
12/12/2013	US20130330333 Treatment of angiogenesis disorders
12/12/2013	US20130330332 Treatment of pemphigus
12/12/2013	US20130330328 Combination Therapy For B Cell Lymphomas
12/12/2013	US20130330327 Alkoxy-substituted 2,3-dihydroimidazo[1,2-c]quinazolines
12/12/2013	US20130330326 Methods of treating cancer
12/12/2013	US20130330324 Antibodies for epidermal growth factor receptor 3 (her3)
12/12/2013	US20130330295 Antigenic gly1 polypeptide
12/12/2013	US20130330275 Misfolded proteins in cancer treatment and diagnosis
12/12/2013	DE112012001046T5 Stabile kolloidale Goldnanopartikel mit kontrollierbarer Oberflächenmodifizierung und Funktionalisierung Stable colloidal gold nanoparticles with controllable surface modification and functionalization
12/12/2013	CA2876150A1 Compostions and methods for cancer immunotherapy
12/12/2013	CA2876139A1 Nanotherapeutics for drug targeting
12/12/2013	CA2875980A1 Binding agents that modulate the hippo pathway and uses thereof
12/12/2013	CA2875752A1 Improved safety testing
12/12/2013	CA2875703A1 Anti-trka antibodies with enhanced inhibitory properties and derivatives thereof
12/12/2013	CA2875683A1 Vaccination with interleukin-4 antagonists
12/12/2013	CA2875681A1 Compositions and methods for treating crohn's disease and related conditions and infections
12/12/2013	CA2875624A1 Hiv vaccine
12/12/2013	CA2875451A1 Antibody against transporter and use thereof
12/12/2013	CA2874936A1 Vaccine
12/12/2013	CA2874923A1 Peptides derived from viral proteins for use as immunogens and dosage reactants
12/11/2013	EP2671891A2 Ang-2 inhibition to treat multiple sclerosis
12/11/2013	EP2671592A2 Vaccine
12/11/2013	EP2671456A1 Novel use of maltotriosyl transferase
12/11/2013	EP2670843A1 Multivalent vaccines for rabies virus and filoviruses
12/11/2013	EP2670775A1 Anti-tace antibody molecules and their uses
12/11/2013	EP2670769A1 R2r1/2 in diagnosis and therapy
12/11/2013	EP2670487A1 Use of an anti-cd200 antibody for prolonging the survival of allografts
12/11/2013	EP2670438A2 Selection and treatment of subjects
12/11/2013	EP2670437A2 Dosing for treatment with anti-egfl7 antibodies
12/11/2013	EP2670436A2 Foxc1 antibodies and methods of their use
12/11/2013	EP2670435A1 Use of anti-dkk1 monoclonal antibody for treatment of liver cancer
12/11/2013	EP2670434A2 Treatment of tauopathies
12/11/2013	EP2670432A1 Immunogenic bordetella bronchiseptica compositions
12/11/2013	EP2670431A1 Compositions for canine respiratory disease complex
12/11/2013	EP2670430A2 Recombinant viral vectors and methods for inducing a heterosubtypic immune response to influenza a viruses
12/11/2013	EP2670425A2 Ubiquitin interacting motif peptides as cancer therapeutics
12/11/2013	EP2670422A1 Antagonism of the vip signaling pathway
12/11/2013	EP2650309A9 Conjugate of folate and antibody, preparation method and use thereof
12/11/2013	EP2083858B1 Human immune therapies using a cd27 agonist alone or in combination with other immune modulators
12/11/2013	CN1798574B Acapsular p. multocida hyae deletion mutants
12/11/2013	CN103443285A Antibodies that specifically bind staphylococcus aureus [alpha] toxin and methods of use
12/11/2013	CN103443125A Low affinity blood brain barrier receptor antibodies and uses therefor
12/11/2013	CN103442733A Treatment of dermatological pathologies
12/11/2013	CN103442732A Nucleic acid molecule encoding hepatitis B virus core protein and vaccine comprising the same
12/11/2013	CN103442731A Expression systems
12/11/2013	CN103442730A A composite heptavalent vaccine
12/11/2013	CN103442729A Treatment and prevention of malaria
12/11/2013	CN103436553A Method for preparing recombinant coxsackievirus A16 type virus-like particles
12/11/2013	CN103436499A Porcine circovirus-like particle, and vaccine and preparation method thereof
12/11/2013	CN103436478A Salmonella enteritidis double knockout attenuated mutant and preparation as well as application thereof
12/11/2013	CN103435698A Sclerostin结合剂 Sclerostin binding agents
12/11/2013	CN103435697A Neutralizing antibodies to influenza viruses
12/11/2013	CN103435695A Antibodies with enhanced antibody-dependent cellular cytoxicity activity, methods of their production and use
12/11/2013	CN103435685A Monoclonal antibody capable of resisting fibrinogen-like protein, and application thereof
12/11/2013	CN103432580A Predicting response to a HER dimerisation inhibitor based on low HER3 expression
12/11/2013	CN103432579A Preparation method of lamb-dysentery clostridium perfringens type B toxoid vaccine
12/11/2013	CN103432578A Preparation method of C-type clostridium perfringens toxin vaccine of piglet red dysentery
12/11/2013	CN103432577A Animal model induced by combination of intraocular antigen immunization and endotoxin, and establishment method thereof
12/11/2013	CN103060274B RANKL-TNF sample region mouse monoclonal antibody and its preparation method and use
12/11/2013	CN102988969B DNA vaccine for expressing avian reticuloendotheliosis virus gp90 gene as well as establishment method and application of gene
12/11/2013	CN102952785B Porcine pseudorabies virus, and vaccine composition and applications thereof
12/11/2013	CN102899294B Vaccine strain of HIN1 swine influenza virus and application thereof
12/11/2013	CN102847146B Vaccine used for preventing tilapia streptococcal disease

1 ... 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 ... 1823